Stuart A. Arbuckle, EVP, COO: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/27

Trade details

Type: Insider sale
Amount: $2,142,973.8
Shares · price: 5,034 sh · $425.70 a share
Held after: 49,691 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Stuart A. ArbuckleEVP, COO
Trade date: 24/02/26
Filed: 24/02/27
Days to filing: 1 days

Sold 9.2% of holdings

Share of holding sold: 9.2%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/27~24/03/27

Stuart A. Arbuckle's recent trades

Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$29.7K
69 sh
$29.7K
Filed 24/05/17
Traded 24/05/15
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.5M
3,603 sh
$1.5M
Filed 24/02/23
Traded 24/02/21
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2M
4,804 sh
$2M
Filed 24/02/21
Traded 24/02/20
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.8M
4,295 sh
$1.8M
Filed 24/02/13
Traded 24/02/12
Stuart A. ArbuckleEVP, COO
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.4M
8,603 sh
$3.4M
Filed 23/12/15
Traded 23/12/13